Alternative splicing (AS) of pre-mRNA plays a crucial role in tissue-specific gene regulation, with disease implications due to splicing defects. Predicting and manipulating AS can therefore uncover ...

AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1bn, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, and ...

Targovax ASA ( ($GB:0RIS) ) just unveiled an announcement. Circio Holding ASA has requested Atlas to subscribe and pay for an additional tranche ...

PLYMOUTH MEETING, PA, USA I March 13, 2025 I INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

ICMR-NIV director discusses India's expanding VRDL network, vaccine manufacturing, viral disease surveillance, and One Health ...

acid medicine, today announces that CEO Dr. Erik Digman Wiklund and CSO Dr. Victor Levitsky are presenting updated data demonstrating the significant well as in vivo testing of the novel circVec 3.0 ...

RNA editing is a widespread post-transcriptional process contributing ... PCR products were subcloned into the T-easy vector (Promega), and approximately 50 individual plasmids were sequenced for each ...

Prior to Curate Biosciences, Haab served as site director for Millipore Sigma where she managed the manufacturing of viral vector drug products ... continuous flow RNA in vitro transcription ...

This prototype operates at a speed that is 10 15 times faster than the fastest supercomputer currently available and one million times faster than the latest results published by Google. This ...